Analyst Research

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$75.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Magellan Health Services Inc Reaffirms FY 2013 EPS Guidance; Revises FY 2013 Revenue Guidance-Conference Call


Wednesday, 13 Mar 2013 02:45pm EDT 

Magellan Health Services Inc announced that it is looking at about $3.5 billion to $3.8 billion in sales, profit to be between $250-$270 million and net income at $91 million to $109 million, with EPS of $3.27 to $3.92 per share. According to I/B/E/S Estimates, analysts are expecting the Company to report revenues of $3.6 billion, net income of $104 million for fiscal 2013. 

Company Quote

58.545
0.285 +0.49%
4:00pm EDT